Cost-effectiveness analyses of population-based multi-gene testing for the prevention of breast and ovarian cancer in the United States. This is an ASCO Meeting Abstract from the 2023 ASCO Annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results